Familial pulmonary capillary hemangiomatosis: genes and variants
Explore variant evidence for Familial pulmonary capillary hemangiomatosis across 1 analyzed protein (EIF2AK4). Linked ClinVar records include 9 pathogenic or likely pathogenic variants, 7 variants of uncertain significance and 3 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Familial pulmonary capillary hemangiomatosis
EIF2AK4: eIF-2-alpha kinase GCN2
It senses amino-acid deprivation and other stresses and reduces global translation through phosphorylation of eIF2alpha. Biallelic loss-of-function variants are a major cause of pulmonary capillary hemangiomatosis and pulmonary veno-occlusive disease.
9 ClinVar pathogenic / likely pathogenic and 9 uncertain variants in EIF2AK4 have source records linked to Familial pulmonary capillary hemangiomatosis. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): BMPR2.
ClinVar pathogenic and likely pathogenic variants linked to Familial pulmonary capillary hemangiomatosis
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| EIF2AK4 R585Q | 585 | Pathogenic / likely pathogenic (★) | |
| EIF2AK4 G599R | 599 | Protein kinase 2 | Pathogenic / likely pathogenic |
| EIF2AK4 L643R | 643 | Protein kinase 2 | Pathogenic / likely pathogenic |
| EIF2AK4 H1202L | 1202 | Histidyl-tRNA synthetase-like | Pathogenic / likely pathogenic |
| EIF2AK4 V607G | 607 | Protein kinase 2 | Pathogenic / likely pathogenic |
| EIF2AK4 S909R | 909 | Protein kinase 2 | Pathogenic / likely pathogenic |
| EIF2AK4 G1109R | 1109 | Histidyl-tRNA synthetase-like | Pathogenic / likely pathogenic |
| EIF2AK4 P1115L | 1115 | Histidyl-tRNA synthetase-like | Pathogenic / likely pathogenic |
| EIF2AK4 L1295R | 1295 | Histidyl-tRNA synthetase-like | Pathogenic / likely pathogenic |
Which prediction tools work for Familial pulmonary capillary hemangiomatosis
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 99 out of 100
- ESM1b (LLR): 98 out of 100
- PolyPhen-2: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 92 out of 100
- MetaSVM: 59 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 51 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Diseases related to Familial pulmonary capillary hemangiomatosis
- Pulmonary arterial hypertension, also linked to EIF2AK4
Frequently asked questions
Which genes have records linked to Familial pulmonary capillary hemangiomatosis?
This view contains 1 analyzed proteins: EIF2AK4. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 9 pathogenic or likely pathogenic variants, 7 variants of uncertain significance and 3 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 25 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center